Published in Cell on February 21, 1992
Cholera. Clin Microbiol Rev (1995) 12.33
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest (2002) 5.94
The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature (2006) 3.66
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A (2008) 3.08
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A (1993) 2.81
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68
Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem (2002) 2.64
Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. Proc Natl Acad Sci U S A (1994) 2.53
The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci U S A (1993) 2.48
Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. J Gen Physiol (2010) 2.09
Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating. J Gen Physiol (2003) 2.03
Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J Physiol (2005) 1.97
Chloride channels: often enigmatic, rarely predictable. Annu Rev Physiol (2010) 1.94
Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme. J Gen Physiol (1999) 1.92
Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest (1994) 1.86
Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner. J Biol Chem (2012) 1.80
Molecular insights into the physiology of the 'thin film' of airway surface liquid. J Physiol (1999) 1.68
Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol (1992) 1.68
Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest (2001) 1.63
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites. J Gen Physiol (1999) 1.61
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet (2009) 1.53
Halide permeation in wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels. J Gen Physiol (1997) 1.51
Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. J Gen Physiol (1997) 1.49
Multi-Ion mechanism for ion permeation and block in the cystic fibrosis transmembrane conductance regulator chloride channel. J Gen Physiol (1997) 1.47
Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci U S A (1994) 1.47
Mechanism of coupling of transport to hydrolysis in bacterial ATP-binding cassette transporters. J Bacteriol (2002) 1.45
CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J (2003) 1.45
Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax (2004) 1.43
CFTR Cl- channel and CFTR-associated ATP channel: distinct pores regulated by common gates. EMBO J (1998) 1.37
Syntaxin 1A inhibits CFTR chloride channels by means of domain-specific protein-protein interactions. Proc Natl Acad Sci U S A (1998) 1.35
Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34
CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. Integr Biol (Camb) (2010) 1.32
Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle. Proc Natl Acad Sci U S A (2013) 1.30
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30
Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J (1995) 1.30
Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut (2007) 1.29
Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol Biol Cell (2003) 1.29
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor. J Cell Biol (1998) 1.26
Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation. J Gen Physiol (2010) 1.26
Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains. Mol Biol Cell (2010) 1.25
Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype. J Clin Invest (1994) 1.23
Regulation of CFTR Cl- channel gating by ADP and ATP analogues. J Gen Physiol (1995) 1.21
Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest (1994) 1.20
Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes. Proc Natl Acad Sci U S A (2000) 1.19
In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium. Proc Natl Acad Sci U S A (1997) 1.19
Regulation of CFTR expression and function during differentiation of intestinal epithelial cells. EMBO J (1992) 1.18
Cystic fibrosis genotypes and views on screening are both heterogeneous and population related. Am J Hum Genet (1992) 1.17
DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther (2010) 1.16
Genetic variation and clinical heterogeneity in cystic fibrosis. Annu Rev Pathol (2011) 1.16
The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosis. Hum Genet (2004) 1.14
Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis. PLoS Genet (2014) 1.14
A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR). Biochem J (1997) 1.13
Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci U S A (1995) 1.13
Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun (2007) 1.13
Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells. J Physiol (1998) 1.13
Cystic fibrosis: a disease of altered protein folding. J Bioenerg Biomembr (1997) 1.12
ATP binding cassette modulators control abscisic acid-regulated slow anion channels in guard cells Plant Cell (1999) 1.11
CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated state. J Gen Physiol (1996) 1.11
Gene therapy for cystic fibrosis: challenges and future directions. J Clin Invest (1995) 1.08
Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells. J Physiol (2002) 1.07
The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J (1992) 1.05
Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins. Biophys J (1995) 1.04
The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR. J Physiol (2011) 1.04
Thermally unstable gating of the most common cystic fibrosis mutant channel (ΔF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J Biol Chem (2011) 1.04
Structural basis for the channel function of a degraded ABC transporter, CFTR (ABCC7). J Gen Physiol (2011) 1.03
Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther (2009) 1.02
Impaired cell volume regulation in intestinal crypt epithelia of cystic fibrosis mice. Proc Natl Acad Sci U S A (1995) 1.01
Endogenous chloride channels of insect sf9 cells. Evidence for coordinated activity of small elementary channel units. J Gen Physiol (1996) 1.01
Identification of an ion channel-forming motif in the primary structure of CFTR, the cystic fibrosis chloride channel. Proc Natl Acad Sci U S A (1994) 1.01
The CFTR ion channel: gating, regulation, and anion permeation. Cold Spring Harb Perspect Med (2013) 1.00
Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas. Future Med Chem (2012) 1.00
Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator. J Physiol (1999) 1.00
Gene therapy for cystic fibrosis. Arch Dis Child (1993) 1.00
Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator. Philos Trans R Soc Lond B Biol Sci (2009) 0.99
Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Invest (1994) 0.99
Molecular analysis of the ovine cystic fibrosis transmembrane conductance regulator gene. Proc Natl Acad Sci U S A (1995) 0.99
Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator. Biophys J (2000) 0.99
Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain. J Biol Chem (2008) 0.97
The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev (2005) 0.97
Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents. Proc Natl Acad Sci U S A (1992) 0.97
Slow conversions among subconductance states of cystic fibrosis transmembrane conductance regulator chloride channel. Biophys J (1996) 0.97
Novel molecular approaches to cystic fibrosis gene therapy. Biochem J (2005) 0.96
Non-specific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep (2001) 0.96
Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem (2013) 0.96
Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin. Proc Natl Acad Sci U S A (2007) 0.96
Airway hydration and COPD. Cell Mol Life Sci (2015) 0.94
GTP-binding proteins inhibit cAMP activation of chloride channels in cystic fibrosis airway epithelial cells. Proc Natl Acad Sci U S A (1992) 0.94
Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein. J Bioenerg Biomembr (1997) 0.94
Identification of a novel post-hydrolytic state in CFTR gating. J Gen Physiol (2012) 0.93
Cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion in vivo. Proc Natl Acad Sci U S A (1996) 0.93
Defective regulation of gap junctional coupling in cystic fibrosis pancreatic duct cells. J Clin Invest (1999) 0.92
CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity. J Cell Sci (2012) 0.91
Nonequilibrium gating of CFTR on an equilibrium theme. Physiology (Bethesda) (2012) 0.91
Activation of endogenous deltaF508 cystic fibrosis transmembrane conductance regulator by phosphodiesterase inhibition. J Clin Invest (1996) 0.90
Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children. Mediators Inflamm (2001) 0.89
Cysteine residues in the nucleotide binding domains regulate the conductance state of CFTR channels. Biophys J (2002) 0.89
Cysteine scanning of CFTR's first transmembrane segment reveals its plausible roles in gating and permeation. Biophys J (2013) 0.88
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol (1989) 4.21
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (1985) 3.97
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci U S A (1976) 3.87
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature (1991) 3.61
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (1985) 3.59
Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell (1991) 3.56
Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science (1985) 3.43
Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14
DEPRESSION OF LYMPHOCYTE CONTENT OF THORACIC DUCT LYMPH BY ADRENOCORTICOTROPHIC HORMONE. Science (1945) 2.97
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem (1993) 2.85
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem (1993) 2.65
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet (1992) 2.64
Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J (1998) 2.55
Regulation of plasma membrane recycling by CFTR. Science (1992) 2.50
Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat Struct Biol (1998) 2.49
Isolation and amino-acid sequence of beta-LPH from sheep pituitary glands. Nature (1965) 2.44
Pharmacology of CFTR chloride channel activity. Physiol Rev (1999) 2.41
ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33
beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A (1976) 2.30
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1994) 2.27
Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol (1985) 2.12
Cytogenetic Effects in Corn Exposed to Atomic Bomb Ionizing Radiation at Bikini. Science (1948) 2.11
DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol (1982) 2.03
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem (1979) 1.98
Synthesis and analgesic activity of human beta-endorphin. J Med Chem (1977) 1.98
Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther (1985) 1.92
Human beta-endorphin: synthesis and characterization of analogs iodinated and tritiated at tyrosine residues 1 and 27. Int J Pept Protein Res (1980) 1.88
Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol (1999) 1.88
A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet (2000) 1.87
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem (1991) 1.86
MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone. Nucleic Acids Res (1987) 1.80
Modulation of Cl- secretion by benzimidazolones. I. Direct activation of a Ca(2+)-dependent K+ channel. Am J Physiol (1996) 1.78
Evidence that the gamma-glutamyl cycle functions in vivo using intracellular glutathione: effects of amino acids and selective inhibition of enzymes. Proc Natl Acad Sci U S A (1978) 1.77
The synthesis of a protein possessing growth-promoting and lactogenic activities. J Am Chem Soc (1970) 1.75
Multidrug resistance. Cancer Surv (1986) 1.75
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates. J Gen Physiol (1993) 1.74
Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J Pharmacol Exp Ther (2001) 1.74
Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep (1983) 1.72
The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet (1993) 1.72
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun (1986) 1.71
Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am J Physiol Cell Physiol (2000) 1.68
Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem (1996) 1.66
Isolation, purification, and characterization of gamma-lipotropic hormone from sheep pituitary glands. Can J Biochem (1967) 1.66
P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol (1987) 1.64
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites. J Gen Physiol (1999) 1.61
CHARACTERIZATION OF GONADOTROPIC HORMONES OF THE HYPOPHYSIS BY THEIR SUGAR AND GLUCOSAMINE CONTENT. Science (1939) 1.59
Primary structure of human beta-lipotropin. Nature (1976) 1.56
ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism. J Gen Physiol (1994) 1.53
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res (1983) 1.53
Human pituitary growth hormone: isolation and properties of two biologically active fragments from plasmin digests. Proc Natl Acad Sci U S A (1974) 1.50
A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am J Physiol (1990) 1.50
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]. Ugeskr Laeger (1990) 1.47
Regulation of CFTR ion channel gating by MgATP. FEBS Lett (1998) 1.46
The synthesis and opiate activity of beta-endorphin. Biochem Biophys Res Commun (1976) 1.46
Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell (1999) 1.45
Functional genomics in mice by tagged sequence mutagenesis. Nat Genet (1997) 1.44
Action of plasmin on ovine beta-lipotropin: revision of the carboxyl terminal sequence. Biochem Biophys Res Commun (1973) 1.42
Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J Biol Chem (1994) 1.42
Isolation, characterization and opiate activity of beta-endorphin from human pituitary glands. Biochem Biophys Res Commun (1976) 1.41
[Hyperlipidemia in children]. Ugeskr Laeger (1993) 1.40
Beta-Endorphin as a potent analgesic by intravenous injection. Nature (1976) 1.40
Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (2001) 1.39
Studies on pituitary lactogenic hormone. XXX. The primary structure of the sheep hormone. Arch Biochem Biophys (1970) 1.39
Transport of gamma-glutamyl amino acids: role of glutathione and gamma-glutamyl transpeptidase. Proc Natl Acad Sci U S A (1979) 1.38
The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem (1992) 1.38
The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating. J Physiol (2000) 1.38
CFTR is a monomer: biochemical and functional evidence. J Membr Biol (2002) 1.38
Human fetal liver contains both zinc- and copper-rich forms of metallothionein. J Biol Chem (1980) 1.35
Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34
Exchange bias of the interface spin system at the Fe/MgO interface. Nat Nanotechnol (2013) 1.34
Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel. J Physiol (1998) 1.33
C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem (1999) 1.32
COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. J Cell Biol (2001) 1.32
Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry (1994) 1.32
Direct action of genistein on CFTR. Pflugers Arch (1997) 1.32
Glibenclamide blockade of CFTR chloride channels. Am J Physiol (1996) 1.30